Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials
Woodhouse, Lisa J; Montgomery, Alan A; Mant, Jonathan; Davis, Barry R; Algra, Ale; Mas, Jean-Louis; Staessen, Jan A; Thijs, Lutgarde; Tonkin, Andrew; Kirby, Adrienne; Pocock, Stuart J; Chalmers, John; Hankey, Graeme J; Spence, J David; Sandercock, Peter; Diener, Hans-Christoph; Uchiyama, Shinichiro; Sprigg, Nikola; Bath, Philip M
(2021) BMC Medical Research Methodology, volume 21, issue 1
(Article)
Abstract
BACKGROUND: Vascular prevention trials typically use dichotomous event outcomes although this may be inefficient statistically and gives no indication of event severity. We assessed whether ordinal outcomes would be more efficient and how to best analyse them. METHODS: Chief investigators of vascular prevention randomised controlled trials that showed evidence of
... read more
either benefit or harm, or were included in a systematic review that overall showed benefit or harm, shared individual participant data from their trials. Ordered categorical versions of vascular event outcomes (such as stroke and myocardial infarction) were analysed using 15 statistical techniques and their results then ranked, with the result with the smallest p-value given the smallest rank. Friedman and Duncan's multiple range tests were performed to assess differences between tests by comparing the average ranks for each statistical test. RESULTS: Data from 35 trials (254,223 participants) were shared with the collaboration. 13 trials had more than two treatment arms, resulting in 59 comparisons. Analysis approaches (Mann Whitney U, ordinal logistic regression, multiple regression, bootstrapping) that used ordinal outcome data had a smaller average rank and therefore appeared to be more efficient statistically than those that analysed the original binary outcomes. CONCLUSIONS: Ordinal vascular outcome measures appear to be more efficient statistically than binary outcomes and provide information on the severity of event. We suggest a potential role for using ordinal outcomes in vascular prevention trials.
show less
Download/Full Text
Keywords: Analysis, Ordinal, Prevention, Vascular event, Epidemiology, Health Informatics
ISSN: 1471-2288
Publisher: BioMed Central
Note: Funding Information: PMB is Stroke Association Professor of Stroke Medicine and is a NIHR Senior Investigator. PMB was Chief Investigator for the ENOS and TARDIS trials, which were shared with the study. LJW was funded in part by UK MRC ENOS (G0501797) and NIHR TARDIS (10/104/24). AAM, JM, BRD, AA, J-LM, JAS, LT AT, AK, SJP, JC, GJH, JDS, PS, HCS, SU & NS report no conflicts of interest. Funding Information: GlaxoSmithKline, Boehringer Ingelheim and MERCK gave free access to their data, but were not involved in study design, data analysis, interpretation or reporting. All methods were carried out in accordance with relevant guidelines and regulations. Publisher Copyright: © 2021, The Author(s).
(Peer reviewed)